Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 2514Session 2025

What changed between versions

8 paragraphs changed+7 words added−10 removed

Highlighted text was added in the newer version. Struck-through text was removed.

ENROLLED

2025

Legislature

SB 2514, 1st Engrossed

First Engrossed (ntc)

20252514e120252514er

1 A bill to be entitled

1

2 An act relating to health and human services; amending

2539 unchanged paragraphs

3 s. 381.4019, F.S.; authorizing certain dental and

4 dental hygiene students to apply for the Dental

5 Student Loan Repayment Program before obtaining active

6 employment; amending s. 381.915, F.S.; revising the

7 definitions of the terms “cancer center” and “Florida

8 based”; defining the term “Cancer Connect

9 Collaborative” or “collaborative”; making clarifying

10 changes; deleting an obsolete date; revising the

11 composition of the collaborative; deleting obsolete

12 provisions; requiring the collaborative to review all

13 submitted Cancer Innovation Fund grant applications

14 using certain parameters; requiring the collaborative

15 to give priority to certain applications; requiring

16 that licensed or certified health care providers,

17 facilities, or entities meet certain criteria to be

18 eligible for specified grant funding; specifying such

19 criteria; requiring the Department of Health to

20 appoint peer review panels for a specified purpose;

21 requiring that priority scores be forwarded to the

22 collaborative and be considered in determining which

23 proposals the collaborative recommends for certain

24 grant funding; requiring the collaborative and peer

25 review panels to establish and follow certain

26 guidelines and adhere to a certain policy; prohibiting

27 a member of the collaborative or a panel from

28 participating in certain discussions or decisions

29 under certain circumstances; requiring, beginning on a

30 specified date and annually thereafter, the

31 collaborative to prepare and submit a specified report

32 to the Governor and the Legislature; requiring that

33 the report include certain information; revising the

34 requirements for a specified report by the department;

35 requiring, beginning on a specified date, that certain

36 allocation agreements include certain information;

37 providing legislative findings; creating the Cancer

38 Connect Collaborative Research Incubator within the

39 department, and overseen by the collaborative, to

40 provide funding for a specified purpose over a

41 specified timeframe; specifying the incubator’s

42 targeted area of cancer research for the first

43 specified timeframe; providing that grants issued

44 through the incubator are contingent upon the

45 appropriation of funds and must be awarded through a

46 specified process; requiring that priority be given to

47 certain applicants; authorizing the prioritization of

48 certain grant proposals; providing that applications

49 for incubator funding may be submitted by specified

50 hospitals; requiring that all qualified applicants

51 have equal access and opportunity to compete for

52 research funding; requiring that incubator grants be

53 recommended by the collaborative and awarded by the

54 department in a certain manner; requiring the

55 department to appoint peer review panels for a

56 specified purpose; requiring that priority scores be

57 forwarded to the collaborative and be considered in

58 determining which proposals the collaborative

59 recommends for funding; requiring the collaborative

60 and peer review panels to establish and follow certain

61 guidelines and adhere to a certain policy; prohibiting

62 a member of the collaborative or a panel from

63 participating in certain discussions or decisions;

64 requiring recipients of incubator grant funds to enter

65 into an allocation agreement with the department;

66 specifying requirements for such allocation

67 agreements; requiring, beginning on a specified date

68 and annually until a specified date, the collaborative

69 to prepare and submit a specified report to the

70 Governor and the Legislature; requiring the

71 collaborative to make a certain recommendation under

72 certain circumstances; requiring that a specified

73 report include certain information; amending s.

74 381.922, F.S.; establishing the Bascom Palmer Eye

75 Institute VisionGen Initiative within the William G.

76 “Bill” Bankhead, Jr., and David Coley Cancer Research

77 Program; providing the purpose of the initiative;

78 providing that funding for the initiative is subject

79 to annual appropriation; amending s. 381.986, F.S.;

80 requiring the department to revoke the medical

81 marijuana use registry registration of qualified

82 patients and caregivers who enter certain pleas or are

83 found guilty of certain offenses; authorizing a person

84 seeking reinstatement of qualified patient or

85 caregiver registration to submit a new application

86 with a certain attestation; providing criminal

87 penalties for knowingly making a false attestation;

88 reviving, reenacting, and amending s. 400.0225, F.S.,

89 relating to consumer satisfaction surveys; requiring

90 the Agency for Health Care Administration to develop

91 user-friendly consumer satisfaction surveys for

92 nursing home facilities; specifying requirements for

93 the surveys; authorizing family members, guardians,

94 and other resident designees to assist the resident in

95 completing the survey; prohibiting employees and

96 volunteers of the facility or of a corporation or

97 business entity with an ownership interest in the

98 facility from attempting to influence a resident’s

99 responses to the survey; requiring the agency to

100 specify certain protocols for administration of the

101 survey; requiring the agency to publish on its website

102 aggregated survey data in a manner that allows for

103 comparison between nursing home facilities; amending

104 s. 400.141, F.S.; requiring medical directors of

105 nursing home facilities to obtain, or to be in the

106 process of obtaining, certain qualifications by a

107 specified date; requiring the agency to include such

108 medical director’s name on each nursing home

109 facility’s online provider profile; requiring nursing

110 home facilities to conduct biennial patient safety

111 culture surveys; specifying requirements for

112 administration of such surveys; requiring nursing home

113 facilities to submit the results of such surveys

114 biennially to the agency in a format specified by

115 agency rule; authorizing nursing home facilities to

116 develop an internal action plan between surveys to

117 identify measures for improvement of the survey and

118 submit such plan to the agency; amending s. 400.191,

119 F.S.; requiring the agency to include the results from

120 specified consumer satisfaction surveys as part of the

121 Nursing Home Guide on its website; amending s.

122 408.051, F.S.; requiring nursing home facilities that

123 maintain certain electronic health records to make

124 available certain data to the agency’s Florida Health

125 Information Exchange program for a specified purpose;

126 authorizing the agency to adopt rules; amending s.

127 408.061, F.S.; exempting nursing homes operated by

128 state agencies from certain financial reporting

129 requirements; requiring the agency to impose

130 administrative fines against nursing homes and home

131 offices of nursing homes for failing to comply with

132 certain reporting requirements; defining the term

133 “violation”; providing construction; requiring the

134 agency to adopt rules; providing requirements for such

135 rules; amending s. 408.08, F.S.; prohibiting nursing

136 homes subject to certain administrative fines from

137 being fined under a specified provision for the same

138 violation; amending s. 409.904, F.S.; providing a

139 presumption of eligibility for continued coverage of

140 certain services for certain persons during a

141 redetermination process; requiring certain persons to

142 notify the agency and the Department of Children and

143 Families of certain material changes; authorizing the

144 department to conduct a redetermination of

145 eligibility; requiring the department to provide

146 certain persons notification and the results of such

147 redeterminations; requiring the agency to seek federal

148 authorization to exempt certain persons from annual

149 redetermination of eligibility by a certain date;

150 requiring the agency and department to develop a

151 certain process; amending s. 409.906, F.S.;

152 authorizing the agency to pay for certain blood-based

153 biomarker tests; amending s. 409.908, F.S.; requiring

154 the agency to revise its methodology for calculating

155 Quality Incentive Program payments; providing

156 requirements for such revision; requiring the agency

157 to submit an annual report to the Governor and the

158 Legislature on payments made under the Quality

159 Incentive Program; specifying requirements for the

160 report; amending s. 409.909, F.S.; revising the number

161 of resident positions for which the agency may

162 allocate certain funding to hospitals and qualifying

163 institutions; deleting provisions creating the

164 Graduate Medical Education Committee within the

165 agency; amending s. 409.91256, F.S.; revising the

166 purpose of the Training, Education, and Clinicals in

167 Health Funding Program; revising the definition of the

168 term “qualified facility”; specifying an allowed

169 reimbursement rate to qualified facilities under the

170 program for nursing students; amending s. 409.967,

171 F.S.; requiring the agency to review certain audit

172 reports for compliance; requiring a certified public

173 accountant to correct certain audit report

174 deficiencies and resubmit the report before the report

175 is considered final; amending s. 409.9745, F.S.;

176 requiring a managed care plan to provide coverage for

177 certain blood-based biomarker tests; amending s.

178 409.977, F.S.; authorizing the agency to exceed a

179 certain amount of financial assistance for a high-cost

180 patient under certain circumstances; requiring the

181 agency to submit a certain annual report to the

182 Legislature beginning on a specified date; requiring

183 that the report contain certain information; amending

184 s. 430.84, F.S.; authorizing the state administering

185 agency to exclude certain areas from designation as

186 service areas under contracts with PACE organizations

187 under certain circumstances; requiring the state to

188 determine whether a certain unmet need exists in a

189 certain area upon receipt of a letter of intent to

190 provide PACE services from a new applicant; requiring

191 such applicants to meet certain requirements;

192 requiring the agency to contract with a third-party

193 vendor to conduct a comprehensive study of nursing

194 home quality incentive programs in other states;

195 providing requirements for the study; requiring the

196 agency to submit a final report on the study to the

197 Governor and the Legislature by a specified date;

198 providing an effective date.

199

200 Be It Enacted by the Legislature of the State of Florida:

201

202 Section 1. Present subsections (5) through (10) of section

203 381.4019, Florida Statutes, are redesignated as subsections (6)

204 through (11), respectively, and a new subsection (5) is added to

205 that section, to read:

206 381.4019 Dental Student Loan Repayment Program.—The Dental

207 Student Loan Repayment Program is established to support the

208 state Medicaid program and promote access to dental care by

209 supporting qualified dentists and dental hygienists who treat

210 medically underserved populations in dental health professional

211 shortage areas or medically underserved areas.

212

(5)

A dental student or dental hygiene student who

213

demonstrates an offer of employment

in

a public health program

214

or private practice as specified in

paragraph

(2)

(a)

may apply

215

for the

loan

program before obtaining active employment but may

216

not be awarded funds from the

loan

program until

he or she meets

217

the requirements of subsection (2)

.

218 Section 2. Present paragraphs (c), (d), and (e) of

219 subsection (3) and present subsections (12) and (13) of section

220 381.915, Florida Statutes, are redesignated as paragraphs (d),

221 (e), and (f) of subsection (3) and subsections (13) and (14),

222 respectively, a new paragraph (c) is added to subsection (3),

223 paragraph (d) is added to subsection (10), a new subsection (12)

224 is added to that section, and paragraph (b) and present

225 paragraph (c) of subsection (3), paragraphs (a), (b), (e), (f),

226 and (h) of subsection (8), and subsections (9) and (11) of that

227 section are amended, to read:

228 381.915 Casey DeSantis Cancer Research Program.—

229 (3) On or before September 15 of each year, the department

230 shall calculate an allocation fraction to be used for

231 distributing funds to participating cancer centers. On or before

232 the final business day of each quarter of the state fiscal year,

233 the department shall distribute to each participating cancer

234 center one-fourth of that cancer center’s annual allocation

235 calculated under subsection (6). The allocation fraction for

236 each participating cancer center is based on the cancer center’s

237 tier-designated weight under subsection (4) multiplied by each

238 of the following allocation factors based on activities in this

239 state: number of reportable cases, peer-review costs, and

240 biomedical education and training. As used in this section, the

241 term:

242 (b) “Cancer center” means a comprehensive center with at

243 least one geographic site in the state, a freestanding center

244 located in the state, a center situated within an academic

245 institution, or a Florida-based formal research-based consortium

246 under centralized leadership that has achieved NCI designation

247

or is prepared to achieve NCI designation by June 30, 2024

.

248

(c) “Cancer Connect Collaborative

” or “collaborative

” means

249

the council created under s

ubs

ection (8).

250

(d)

(c)

“Florida-based” means that a cancer center’s actual

251 or sought designated status is or would be recognized by the NCI

252 as primarily located in Florida and not in another state

, or

253

that a health care provider or facility is physically located in

254

Florida and provides services in Florida

.

255 (8) The Cancer Connect Collaborative, a council as defined

256 in s. 20.03, is created within the department to advise the

257 department and the Legislature on developing a holistic approach

258 to the state’s efforts to fund cancer research, cancer

259 facilities, and treatments for cancer patients. The

260 collaborative may make recommendations on proposed legislation,

261 proposed rules, best practices, data collection and reporting,

262 issuance of grant funds, and other proposals for state policy

263 relating to cancer research or treatment.

264 (a) The Surgeon General shall serve as an ex officio,

265 nonvoting member

of the collaborative

and shall serve as the

266 chair.

267 (b) The collaborative shall be composed of the following

268 voting members

, to be appointed by September 1, 2024

:

269 1. Two members appointed by the Governor,

t

hree

members

one

270

member

appointed by the President of the Senate, and

t

hree

271

members

one member

appointed by the Speaker of the House of

272 Representatives, based on the criteria of this subparagraph. The

273 appointing officers shall make their appointments prioritizing

274 members who have the following experience or expertise:

275 a. The practice of a health care profession specializing in

276 oncology clinical care or research;

277 b. The development of preventive and therapeutic treatments

278 to control cancer;

279 c. The development of innovative research into the causes

280 of cancer, the development of effective treatments for persons

281 with cancer, or cures for cancer; or

282 d. Management-level experience with a cancer center

283 licensed under chapter 395.

284 2. One member who is a resident of this state who can

285 represent the interests of cancer patients in this state,

286 appointed by the Governor.

287 (e) Members

of the collaborative

whose terms have expired

288 may continue to serve until replaced or reappointed, but for no

289 more than 6 months after the expiration of their terms.

290 (f) Members

of the collaborative

shall serve without

291 compensation but are entitled to reimbursement for per diem and

292 travel expenses pursuant to s. 112.061.

293

(h)

The collaborative shall develop a long-range

294

comprehensive plan for the Casey DeSantis Cancer Research

295

Program. In the development of the plan, the collaborative must

296

solicit input from cancer centers, research institutions,

297

biomedical education institutions, hospitals, and medical

298

providers. The collaborative shall submit the plan to the

299

Governor, the President of the Senate, and the Speaker of the

300

House of Representatives no later than December 1, 2024. The

301

plan must include, but need not be limited to, all of the

302

following components:

303

1. Expansion of grant fund opportunities to include a

304

broader pool of Florida-based cancer centers, research

305

institutions, biomedical education institutions, hospitals, and

306

medical providers to receive funding through the Cancer

307

Innovation Fund.

308

2. An evaluation to determine metrics that focus on patient

309

outcomes, quality of care, and efficacy of treatment.

310

3. A compilation of best practices relating to cancer

311

research or treatment

.

312 (9)

(a)

The collaborative shall advise the department on the

313 awarding of grants issued through the Cancer Innovation Fund.

314 During any fiscal year for which funds are appropriated to the

315 fund, the collaborative shall review all submitted grant

316 applications

using the parameters provided in

paragraph (

c

)

and

317 make recommendations to the department for awarding grants to

318 support innovative cancer research and treatment models,

319 including emerging research and treatment trends and promising

320 treatments that may serve as catalysts for further research and

321 treatments. The department shall make the final grant allocation

322 awards. The collaborative shall give priority to applications

323 seeking to expand the reach of

cancer screening efforts and

324 innovative cancer treatment models into underserved areas of

325 this state.

326

(

b

)

To be eligible for grant funding under this subsection,

327

a

licensed or certified health care provider, facility, or

328

entity

must

meet

at least one of

the following criteria

:

329

1

. Operate

s

as

a licensed hospital that has a minimum of 30

330

percent

of

its

current cancer patients

residing

in rural or

331

underserved areas

.

332

2

. Operate

s

as

a licensed health care clinic or facility

333

that employs or contracts with at least one physician

licensed

334

under chapter 458 or chapter 459

who

is board certified

in

335

oncology and that

administers

chemotherapy treatments for

336

cancer

.

337

3

. Operate

s

as

a licensed facility that employs or

338

contracts with at least one

physician licensed under chapter 458

339

or chapter 459 who is board

certified in oncology

and that

340

administers

radiation therapy treatments for cancer

.

341

4.

Operate

s

as

a licensed health care clinic or facility

342

that provides cancer screening services at no cost or a minimal

343

cost to patients.

344

5

. Operate

s

as a rural hospital as defined in s.

345

395.602(2)(b)

.

346

6

. Operate

s

as a critical access hospital as defined in s.

347

408.07(14)

.

348

7

. Operate

s

as a specialty hospital as defined in s.

349

395.002(28)(a)

which

provides cancer treatment for

patients

from

350

birth to

18 years

of age.

351

8

.

Operates as a licensed hospital that is accredited by

352

the American College of Surgeons as a Comprehensive Community

353

Cancer Program or Integrated Network Cancer Program.

354

9.

Engage

s

in biomedical research intended to develop

355

therapies, medical pharmaceuticals, treatment protocols, or

356

medical procedures intended to cure cancer or improve the

357

quality of life of cancer patients

.

358

10

. Educate

s

or train

s

students, postdoctoral fellows, or

359

licensed or certified health care practitioners in the

360

screening, diagnosis, or treatment of cancer.

361

(

c

) To ensure that all proposals for

grant funding

issued

362

through the Cancer Innovation Fund are appropriate and are

363

evaluated fairly on the basis of scientific merit, the

364

department shall appoint peer review panels of independent,

365

scientifically qualified individuals to review the scientific

366

merit of each proposal and establish its priority score. The

367

priority scores

must

be forwarded to the collaborative and must

368

be considered in determining which proposals the collaborative

369

recommends

for grant funding through the

Cancer Innovation Fund.

370

(

d

) The collaborative and the peer review panels shall

371

establish and follow rigorous guidelines for ethical conduct and

372

adhere to a strict policy with regard to conflicts of interest

373

regarding the assessment of Cancer Innovation Fund grant

374

applications. A member of the collaborative or a panel may not

375

participate in any discussion or decision of the collaborative

376

or a panel with respect to a research proposal by any firm,

377

entity, or agency with which the member is associated as a

378

member of the governing body or as an employee or with which the

379

member has entered into a contractual arrangement.

380

(

e

)

Beginning December 1, 2025, and annually thereafter,

381

t

he collaborative shall

prepare and submit

a report to the

382

Governor,

the

President of the Senate, and

the

Speaker of the

383

House of Representative

s

which

identifies and evaluates

the

384

performance and

the impact

of

grants issued through

the

Cancer

385

Innovation Fund

on cancer treatment,

research,

screening,

386

diagnosis, prevention, practitioner

training,

workforce

387

education, and

cancer patient

survivorship. The report

must

388

include

all of

the following:

389

1

. Amounts of grant funds awarded to each

recipient

.

390

2

. Descriptions of each

recipien

t’s research or project

391

which

include

, but need not be limited to,

the following:

392

a.

Goals or projected outcomes

.

393

b.

Population to be served

.

394

c.

Research methods or project implementation plan

.

395

3

.

An assessment of

grant recipients

which

evaluates

their

396

p

rogress

toward achieving objectives specified in

each

397

recipient’s

grant application.

398

4

.

Recommendations for best practices

that may

be

399

implemented by health care providers in

this state

who

diagnose,

400

treat, and screen for cancer

, based on the outcomes of projects

401

funded through the Cancer Innovation Fund

.

402 (10) Beginning July 1, 2025, and each year thereafter, the

403 department, in conjunction with participating cancer centers,

404 shall submit a report to the Cancer Control and Research

405 Advisory Council and the collaborative on specific metrics

406 relating to cancer mortality and external funding for cancer

407 related research in this state. If a cancer center does not

408 endorse this report or produce an equivalent independent report,

409 the cancer center is ineligible to receive program funding for 1

410 year. The department must submit this annual report, and any

411 equivalent independent reports, to the Governor, the President

412 of the Senate, and the Speaker of the House of Representatives

413 no later than September 15 of each year the report or reports

414 are submitted by the department. The report must include:

415

(d) A description of the numbers and types of cancer cases

416

treated

annually at each participating cancer center

, including

417

reportable and nonreportable cases

.

418 (11) Beginning July 1,

2025

2024

, each allocation agreement

419 issued by the department relating to cancer center payments

420 under

paragraph (2)(a)

subsection (2)

must include all of the

421 following:

422 (a) A line-item budget narrative documenting the annual

423 allocation of funds to a cancer center.

424 (b) A cap on the annual award of 15 percent for

425 administrative expenses.

426 (c) A requirement for the cancer center to submit quarterly

427 reports of all expenditures made by the cancer center with funds

428 received through the Casey DeSantis Cancer Research Program.

429 (d) A provision to allow the department and other state

430 auditing bodies to audit all financial records, supporting

431 documents, statistical records, and any other documents

432 pertinent to the allocation agreement.

433 (e) A provision requiring the annual reporting of outcome

434 data and protocols used in achieving those outcomes.

435

(12)(a)

The Legislature finds that targeted areas of cancer

436

research require increased resources and that Florida should

437

become a leader in promoting research opportunities for these

438

targeted areas. Floridians should not have to leave the state to

439

receive the most advanced cancer care and treatment. To meet

440

this need, the Cancer Connect Collaborative Research Incubator

,

441

or “incubator” as used in this subsection,

is created within the

442

department, to be overseen by the collaborative, to provide

443

funding for a targeted area of cancer research

over

a

5

-year

444

period. For the

5

-year period beginning July 1, 2025, the

445

i

ncubator’s targeted area of cancer research

is

pediatric

446

cancer.

447

(b)

Contingent

up

on the appropriation of funds by the

448

Legislature, grants issued through the

i

ncubator

must

be awarded

449

through a peer-reviewed, competitive process.

Priority

must

be

450

given to applicants that focus on

enhancing

both research and

451

treatment

by increasing

participation in clinical trials

related

452

to the targeted area of cancer research, including

all of the

453

following

:

454

1. Identifying

strategies

to increase enrollment in cancer

455

clinical trials

.

456

2. Supporting public and private professional education

457

programs

to raise

awareness and knowledge about cancer clinical

458

trials

.

459

3. Providing tools

for

cancer patients and community-based

460

oncologists to

help identify available cancer clinical trials i

n

461

th

is

state

.

462

4. Creating opportunities for the state’s academic cancer

463

centers to collaborate with community-based oncologists in

464

cancer clinical trial

networks.

465

(c)

Priority

may be given to grant proposals that foster

466

collaborations among institutions, researchers, and community

467

practitioners to support the advancement of cures through basic

468

or applied research, including clinical trials involving cancer

469

patients and related networks.

470

(d) Applications for

i

ncubator funding may be submitted by

471

any Florida-based specialty hospital as defined in s.

472

395.002(28)(a)

which

provides cancer treatment for patients from

473

birth to 18 years

of age

. All qualified applicants

must

have

474

equal access and opportunity to compete for research funding.

475

Incubator grants

must

be recommended by the collaborative and

476

awarded by the department on the basis of scientific merit, as

477

determined by a competitively open and peer-reviewed process to

478

ensure objectivity, consistency, and high quality.

479

(e) To ensure that all proposals for research funding are

480

appropriate and are evaluated fairly on the basis of scientific

481

merit, the department shall appoint peer review panels of

482

independent, scientifically qualified individuals to review the

483

scientific merit of each proposal and establish its priority

484

score. The priority scores

must

be forwarded to the

485

collaborative and must be considered in determining which

486

proposals the collaborative recommends for funding.

487

(f) The collaborative and the peer review panels shall

488

establish and follow rigorous guidelines for ethical conduct and

489

adhere to a strict policy with regard to conflicts of interest

490

regarding the assessment of incubator grant applications

. A

491

member of the collaborative or a panel may not participate in

492

any discussion or decision of the collaborative or a panel

493

regarding

a research proposal

from

any firm, entity, or agency

494

with which the member is associated

as a governing body member,

495

as an employee, or through

a contractual arrangement.

496

(g) Each recipient of

i

ncubator grant funds must enter into

497

an allocation agreement with the department. Each such

498

allocation agreement must include all of the following:

499

1. A line-item budget narrative documenting the annual

500

allocation of funds to a recipient.

501

2. A cap on the annual award of 15 percent for

502

administrative expenses.

503

3. A requirement for the recipient to submit quarterly

504

reports of all expenditures made by the recipient with funds

505

received through the

incubator.

506

4. A provision to allow the department and other state

507

auditing bodies to audit all financial records, supporting

508

documents, statistical records, and any other documents

509

pertinent to the allocation agreement.

510

5. A provision requiring the annual reporting of outcome

511

data and protocols used in achieving those outcomes.

512

(h) Beginning December 1, 2026, and annually through

513

December 1, 2030, the collaborative shall

prepare and

submit a

514

report to the Governor,

the

President of the Senate, and

the

515

Speaker of the House of Representatives

which

evaluates research

516

conducted through the

i

ncubator and provides details on outcomes

517

and findings available through the end of the fiscal year

518

immediately preceding each report. If the collaborative

519

recommend

s

that the

i

ncubator be extended beyond its

5

-year

520

lifespan, the collaborative shall make such recommendation in

521

the report due December 1, 2029, and shall include a

522

recommendation for the next targeted area of cancer research.

523

The report due on December 1, 2030, must include

all of the

524

following

:

525

1.

Details of all results of the research conducted with

526

i

ncubator funding

which

has been completed or the status of

527

research in progress.

528

2.

An evaluation of all research conducted with

i

ncubator

529

funding during the

5

fiscal years preceding the report.

530 Section 3. Paragraph (d) is added to subsection (2) of

531 section 381.922, Florida Statutes, to read:

532 381.922 William G. “Bill” Bankhead, Jr., and David Coley

533 Cancer Research Program.—

534 (2) The program shall provide grants for cancer research to

535 further the search for cures for cancer.

536

(d) There is established within the program the

Bascom

537

Palmer Eye Institute

VisionGen

Initiative. The purpose of the

538

initiative is to advance

genetic and epigenetic research on

539

inherited eye diseases and ocular oncology

by awarding grants

540

through the peer-reviewed, competitive process established under

541

subsection (3).

Funding for the initiative

is subject to the

542

annual appropriation of funds by the Legislature.

543 Section 4. Paragraphs (d) and (e) of subsection (5) of

544 section 381.986, Florida Statutes, are amended to read:

545 381.986 Medical use of marijuana.—

546 (5) MEDICAL MARIJUANA USE REGISTRY.—

547 (d) The department shall immediately suspend the

548 registration of a qualified patient charged with a violation of

549 chapter 893 until final disposition of

the

any

alleged offense.

550

Based upon such final disposition

Thereafter

, the department may

551 extend the suspension, revoke the registration, or reinstate the

552 registration.

However, the department must revoke the

553

registration of

the

qualified patient upon

such

final

554

disposition

if

the qualified patient

was convicted of, or pled

555

guilty or nolo contendere to, regardless of adjudication, a

556

violation of chapter 893 if such violation was for trafficking

557

in, the sale, manufacture, or delivery of, or possession with

558

intent to sell, manufacture, or deliver a controlled substance.

559

If such person wishes to seek reinstatement of his or her

560

registration as a qualified patient, the person may submit a new

561

application accompanied by a notarized attestation by the

562

applicant that he or she has completed all terms of

563

incarceration, probation, community control, or supervision

564

related to the offense. A person who knowingly makes a false

565

attestation under this paragraph

commits

a misdemeanor of the

566

second degree, punishable as provided in s. 775.082 or s.

567

775.083

.

568 (e) The department shall immediately suspend the

569 registration of

a

any

caregiver charged with a violation of

570 chapter 893 until final disposition of

the

any

alleged offense.

571

The department

must

revoke the registration of

the

caregiver

572

upon

such final disposition if

the caregiver

was convicted of,

573

or pled guilty or nolo contendere to, regardless of

574

adjudication, a violation of chapter 893 if such violation was

575

for trafficking in, the sale, manufacture, or delivery of, or

576

possession with intent to sell, manufacture, or deliver a

577

controlled substance. If such person wishes to seek

578

reinstatement of his or her registration as a caregiver, the

579

person may submit a new application accompanied by a notarized

580

attestation by the applicant that he or she has completed all

581

terms of incarceration, probation, community control, or

582

supervision related to the offense. A person who knowingly makes

583

a false attestation under this paragraph

commits

a misdemeanor

584

of the second degree, punishable as provided in s. 775.082 or s.

585

775.083. Additionally

,

the department

must

shall

revoke a

586 caregiver registration if the caregiver does not meet the

587 requirements of subparagraph (6)(b)6.

588 Section 5. Notwithstanding the repeal of section 400.0225,

589 Florida Statutes, in section 14 of chapter 2001-377, Laws of

590 Florida, that section is revived, reenacted, and amended to

591 read:

592 400.0225 Consumer satisfaction surveys.—

593

(1)

The agency

shall develop user-friendly consumer

594

satisfaction surveys to capture resident and family member

595

satisfaction with care provided by nursing home facilities. The

596

consumer satisfaction surveys must be based on a core set of

597

c

onsu

mer satisfaction questions to allow

for

consistent

598

measurement and must be administered annually to a random sample

599

of long-stay and short-stay residents of each facility and their

600

family members. The survey tool must be based on an agency

601

validated survey instrument whose measures have received an

602

endorsement by the National Quality Forum.

603

(2)

Family members, guardians, or other resident designees

604

may assist a resident in completing the

consumer

satisfaction

605

survey.

606

(3)

Employees and volunteers of the

nursing home

facility

607

or of a corporation or business entity with an ownership

608

interest in the

nursing home

facility are prohibited from

609

attempting to influence a resident’s responses to the consumer

610

satisfaction survey.

611

(4)

The agency shall specify the protocols for conducting

612

the consumer satisfaction survey

s

, ensuring survey validity,

613

reporting survey results, and protecting the identity of

614

individual respondents.

The agency shall make a

ggregated survey

615

data available to consumers on the agency’s website pursuant to

616

s. 400.191(2)(a)15. in a manner that allows for

comparison

617

between

nursing

home facilities

, or its contractor, in

618

consultation with the nursing home industry and consumer

619

representatives, shall develop an easy-to-use consumer

620

satisfaction survey, shall ensure that every nursing facility

621

licensed pursuant to this part participates in assessing

622

consumer satisfaction, and shall establish procedures to ensure

623

that, at least annually, a representative sample of residents of

624

each facility is selected to participate in the survey. The

625

sample shall be of sufficient size to allow comparisons between

626

and among facilities. Family members, guardians, or other

627

resident designees may assist the resident in completing the

628

survey. Employees and volunteers of the nursing facility or of a

629

corporation or business entity with an ownership interest in the

630

facility are prohibited from assisting a resident with or

631

attempting to influence a resident’s responses to the consumer

632

satisfaction survey. The agency, or its contractor, shall survey

633

family members, guardians, or other resident designees. The

634

agency, or its contractor, shall specify the protocol for

635

conducting and reporting the consumer satisfaction surveys.

636

Reports of consumer satisfaction surveys shall protect the

637

identity of individual respondents. The agency shall contract

638

for consumer satisfaction surveys and report the results of

639

those surveys in the consumer information materials prepared and

640

distributed by the agency

.

641

(5)

The agency may adopt rules

as necessary

to

implement

642

administer

this section.

643 Section 6. Paragraph (b) of subsection (1) of section

644 400.141, Florida Statutes, is amended, and paragraph (x) is

645 added to that subsection, to read:

646 400.141 Administration and management of nursing home

647 facilities.—

648 (1) Every licensed facility shall comply with all

649 applicable standards and rules of the agency and shall:

650 (b) Appoint a medical director licensed pursuant to chapter

651 458 or chapter 459.

By January 1, 2026,

the

medical director

of

652

each nursing home facility

must

obtain designation

as a

653

certified medical director by the American Medical Directors

654

Association, hold a similar credential bestowed by an

655

organization recognized by the agency, or be in the process of

656

seeking such designation or credential

ing

, according to

657

parameters adopted

by

agency rule. The agency shall include the

658

name of each nursing home

facility

’s medical director on the

659

facility’s provider profile published by the agency on its

660

website.

The agency may establish by rule more specific criteria

661 for the appointment of a medical director.

662

(x) Conduct, at least biennially, a patient safety culture

663

survey using the applicable Survey on Patient Safety Culture

664

developed by the federal Agency for Healthcare Research and

665

Quality. Each facility shall conduct the survey anonymously to

666

encourage completion of the survey by staff working in or

667

employed by the facility. A facility may contract

with a third

668

party

to administer the survey. Each facility shall biennially

669

submit the survey data to the agency in a format specified by

670

agency

rule, which must include the survey participation rate.

671

Each facility may develop an internal action plan between

672

conducting surveys to identify measures to improve the survey

673

and submit

such

plan to the agency.

674 Section 7. Paragraph (a) of subsection (2) of section

675 400.191, Florida Statutes, is amended to read:

676 400.191 Availability, distribution, and posting of reports

677 and records.—

678 (2) The agency shall publish the Nursing Home Guide

679 quarterly in electronic form to assist consumers and their

680 families in comparing and evaluating nursing home facilities.

681 (a) The agency shall provide an Internet site which

must

682

shall

include at least the following information either directly

683 or indirectly through a link to another established site or

684 sites of the agency’s choosing:

685 1. A section entitled “Have you considered programs that

686 provide alternatives to nursing home care?” which

must

shall

be

687 the first section of the Nursing Home Guide and

must

which shall

688 prominently display information about available alternatives to

689 nursing homes and how to obtain additional information regarding

690 these alternatives. The Nursing Home Guide

must

shall

explain

691 that this state offers alternative programs that

allow

permit

692 qualified elderly persons to stay in their homes instead of

693 being placed in nursing homes and

must

shall

encourage

694 interested persons to call the Comprehensive Assessment Review

695 and Evaluation for Long-Term Care Services (CARES) Program to

696 inquire

as to whether

if

they qualify. The Nursing Home Guide

697

must

shall

list available home and community-based programs

and

698

must

which shall

clearly state the services that are provided

,

699

including

and indicate

whether nursing home services are

covered

700

under those programs when necessary

included if needed

.

701 2. A list by name and address of all nursing home

702 facilities in this state, including any prior name by which a

703 facility was known during the previous 24-month period.

704 3. Whether such nursing home facilities are proprietary or

705 nonproprietary.

706 4. The current owner of the facility’s license and the year

707 that that entity became the owner of the license.

708 5. The name of the owner or owners of each facility and

709 whether the facility is affiliated with a company or other

710 organization owning or managing more than one nursing facility

711 in this state.

712 6. The total number of beds in each facility and the most

713 recently available occupancy levels.

714 7. The number of private and semiprivate rooms in each

715 facility.

716 8. The religious affiliation, if any, of each facility.

717 9. The languages spoken by the administrator and staff of

718 each facility.

719 10. Whether or not each facility accepts Medicare or

720 Medicaid recipients or insurance, health maintenance

721 organization, United States Department of Veterans Affairs,

722 CHAMPUS program, or workers’ compensation coverage.

723 11. Recreational and other programs available at each

724 facility.

725 12. Special care units or programs offered at each

726 facility.

727 13. Whether the facility is a part of a retirement

728 community that offers other services pursuant to part III of

729 this chapter or part I or part III of chapter 429.

730 14. Survey and deficiency information, including all

731 federal and state recertification, licensure, revisit, and

732 complaint survey information, for each facility. For

733 noncertified nursing homes, state survey and deficiency

734 information, including licensure, revisit, and complaint survey

735 information, shall be provided.

736

15. The results of consumer satisfaction surveys conducted

737

pursuant to s. 400.0225

.

738 Section 8. Present subsections (6) and (7) of section

739 408.051, Florida Statutes, are redesignated as subsections (7)

740 and (8), respectively, and a new subsection (6) is added to that

741 section, to read:

742 408.051 Florida Electronic Health Records Exchange Act.—

743

(6) NURSING HOME DATA.—A nursing home facility as defined

744

in s. 400.021 which maintains certified electronic health record

745

technology

shall

make available

all admission

, transfer, and

746

discharge data to the agency’s Florida Health Information

747

Exchange program for the purpose of supporting public health

748

data registries and patient care coordination. The agency may

749

adopt rules to implement this subsection

.

750 Section 9. Present subsections (7) through (15) of section

751 408.061, Florida Statutes, are redesignated as subsections (8)

752 through (16), respectively, a new subsection (7) is added to

753 that section, and subsections (5) and (6) of that section are

754 amended, to read:

755 408.061 Data collection; uniform systems of financial

756 reporting; information relating to physician charges;

757 confidential information; immunity.—

758 (5) Within 120 days after the end of its fiscal year, each

759 nursing home as defined in s. 408.07

, excluding nursing homes

760

operated by state agencies,

shall file with the agency, on forms

761 adopted by the agency and based on the uniform system of

762 financial reporting, its actual financial experience for that

763 fiscal year, including expenditures, revenues, and statistical

764 measures. Such data may be based on internal financial reports

765 that are certified to be complete and accurate by the chief

766 financial officer of the nursing home. However, a nursing home’s

767 actual financial experience shall be its audited actual

768 experience. This audited actual experience must include the

769 fiscal year-end balance sheet, income statement, statement of

770 cash flow, and statement of retained earnings and must be

771 submitted to the agency in addition to the information filed in

772 the uniform system of financial reporting. The financial

773 statements must tie to the information submitted in the uniform

774 system of financial reporting, and a crosswalk must be submitted

775 along with the financial statements.

776 (6) Within 120 days after the end of its fiscal year, the

777 home office of each nursing home as defined in s. 408.07

,

778

excluding nursing homes operated by state agencies,

shall file

779 with the agency, on forms adopted by the agency and based on the

780 uniform system of financial reporting, its actual financial

781 experience for that fiscal year, including expenditures,

782 revenues, and statistical measures. Such data may be based on

783 internal financial reports that are certified to be complete and

784 accurate by the chief financial officer of the nursing home.

785 However, the home office’s actual financial experience shall be

786 its audited actual experience. This audited actual experience

787 must include the fiscal year-end balance sheet, income

788 statement, statement of cash flow, and statement of retained

789 earnings and must be submitted to the agency in addition to the

790 information filed in the uniform system of financial reporting.

791 The financial statements must tie to the information submitted

792 in the uniform system of financial reporting, and a crosswalk

793 must be submitted along with the audited financial statements.

794

(7)

(a)

Beginning January 1, 2026, the agency shall impose

795

an administrative fine of $10,000 per violation against a

796

nursing home or

home office that fails to comply with

subsection

797

(

5

)

or subsection (6), as applicable

. For purposes of this

798

paragraph, the term “violation” means failing to file the

799

financial report required by

subsection

(

5

)

or subsection (6),

800

as applicable,

on or before the report’s due date. Failing to

801

file the report during any subsequent 10-day period occurring

802

after the due date constitutes a separate violation until the

803

report has been submitted.

804

(b)

The agency shall adopt rules to implement this

805

subsection

. The rules must include provisions for a

nursing home

806

or

home office to present factors in mitigation of the

807

imposition of the fine’s full dollar amount. The agency may

808

determine not to impose the fine’s full dollar amount upon a

809

showing that the full fine is inappropriate under the

810

circumstances.

811 Section 10. Subsection (2) of section 408.08, Florida

812 Statutes, is amended to read:

813 408.08 Inspections and audits; violations; penalties;

814 fines; enforcement.—

815 (2) Any health care facility that refuses to file a report,

816 fails to timely file a report, files a false report, or files an

817 incomplete report and upon notification fails to timely file a

818 complete report required under s. 408.061; that violates this

819 section, s. 408.061, or s. 408.20, or rule adopted thereunder;

820 or that fails to provide documents or records requested by the

821 agency under this chapter shall be punished by a fine not

822 exceeding $1,000 per day for each day in violation, to be

823 imposed and collected by the agency. Pursuant to rules adopted

824 by the agency, the agency may, upon a showing of good cause,

825 grant a one-time extension of any deadline for a health care

826 facility to timely file a report as required by this section, s.

827 408.061, or s. 408.20.

A facility fined under s. 408.061(7) may

828

not be additionally fined under this subsection for the same

829

violation.

830 Section 11. Subsection (1) of section 409.904, Florida

831 Statutes, is amended to read:

832 409.904 Optional payments for eligible persons.—The agency

833 may make payments for medical assistance and related services on

834 behalf of the following persons who are determined to be

835 eligible subject to the income, assets, and categorical

836 eligibility tests set forth in federal and state law. Payment on

837 behalf of these Medicaid eligible persons is subject to the

838 availability of moneys and any limitations established by the

839 General Appropriations Act or chapter 216.

840 (1)

(a)

Subject to federal waiver approval, a person who is

841 age 65 or older or is determined to be disabled, whose income is

842 at or below 88 percent of the federal poverty level, whose

843 assets do not exceed established limitations, and who is not

844 eligible for Medicare or, if eligible for Medicare, is also

845 eligible for and receiving Medicaid-covered institutional care

846 services, hospice services, or home and community-based

847 services. The agency shall seek federal authorization through a

848 waiver to provide this coverage.

849

(b)1. A person who was initially determined eligible for

850

Medicaid under paragraph (a) and is receiving Medicaid-covered

851

institutional care services or hospice services, or a person who

852

is receiving home and community-based services pursuant to s.

853

393.066 or s. 409.978, shall be presumed eligible for continued

854

coverage for

such

Medicaid-covered services during any

855

redetermination process, and the agency shall continue to make

856

payments for such services, unless the person experiences a

857

material change in his or her disability or economic status

858

which results in a loss of eligibility. In the event of such a

859

change in disability or economic status, the person or his or

860

her designated caregiver or responsible party

must

notify the

861

agency and the Department of Children and Families of such

862

change, and the

d

epartment may conduct a redetermination of

863

eligibility. If such redetermination is conducted, the

864

d

epartment must notify the person or his or her designated

865

caregiver or responsible party before the commencement of the

866

redetermination and, at its conclusion, the results of the

867

redetermination.

868

2. The agency shall, no later than October 1, 2025, seek

869

federal authorization to exempt a Medicaid-eligible disabled

870

person from annual redetermination of eligibility pursuant to

871

this paragraph.

872

3. The agency and the

d

epartment shall develop a process to

873

facilitate the notifications required under subparagraph 1.

874 Section 12. Paragraph (d) of subsection (29) of section

875 409.906, Florida Statutes, is amended to read:

876 409.906 Optional Medicaid services.—Subject to specific

877 appropriations, the agency may make payments for services which

878 are optional to the state under Title XIX of the Social Security

879 Act and are furnished by Medicaid providers to recipients who

880 are determined to be eligible on the dates on which the services

881 were provided. Any optional service that is provided shall be

882 provided only when medically necessary and in accordance with

883 state and federal law. Optional services rendered by providers

884 in mobile units to Medicaid recipients may be restricted or

885 prohibited by the agency. Nothing in this section shall be

886 construed to prevent or limit the agency from adjusting fees,

887 reimbursement rates, lengths of stay, number of visits, or

888 number of services, or making any other adjustments necessary to

889 comply with the availability of moneys and any limitations or

890 directions provided for in the General Appropriations Act or

891 chapter 216. If necessary to safeguard the state’s systems of

892 providing services to elderly and disabled persons and subject

893 to the notice and review provisions of s. 216.177, the Governor

894 may direct the Agency for Health Care Administration to amend

895 the Medicaid state plan to delete the optional Medicaid service

896 known as “Intermediate Care Facilities for the Developmentally

897 Disabled.” Optional services may include:

898 (29) BIOMARKER TESTING SERVICES.—

899 (d) This subsection does not require coverage of biomarker

900 testing for screening purposes.

The agency

may pay for blood

901

based biomarker tests at an in-network or out-of-network

902

laboratory facility for colorectal cancer screening covered

903

under a National Coverage Determination from the Centers for

904

Medicare and Medicaid Services

.

905 Section 13. Paragraph (b) of subsection (2) of section

906 409.908, Florida Statutes, is amended to read:

907 409.908 Reimbursement of Medicaid providers.—Subject to

908 specific appropriations, the agency shall reimburse Medicaid

909 providers, in accordance with state and federal law, according

910 to methodologies set forth in the rules of the agency and in

911 policy manuals and handbooks incorporated by reference therein.

912 These methodologies may include fee schedules, reimbursement

913 methods based on cost reporting, negotiated fees, competitive

914 bidding pursuant to s. 287.057, and other mechanisms the agency

915 considers efficient and effective for purchasing services or

916 goods on behalf of recipients. If a provider is reimbursed based

917 on cost reporting and submits a cost report late and that cost

918 report would have been used to set a lower reimbursement rate

919 for a rate semester, then the provider’s rate for that semester

920 shall be retroactively calculated using the new cost report, and

921 full payment at the recalculated rate shall be effected

922 retroactively. Medicare-granted extensions for filing cost

923 reports, if applicable, shall also apply to Medicaid cost

924 reports. Payment for Medicaid compensable services made on

925 behalf of Medicaid-eligible persons is subject to the

926 availability of moneys and any limitations or directions

927 provided for in the General Appropriations Act or chapter 216.

928 Further, nothing in this section shall be construed to prevent

929 or limit the agency from adjusting fees, reimbursement rates,

930 lengths of stay, number of visits, or number of services, or

931 making any other adjustments necessary to comply with the

932 availability of moneys and any limitations or directions

933 provided for in the General Appropriations Act, provided the

934 adjustment is consistent with legislative intent.

935 (2)

936 (b) Subject to any limitations or directions in the General

937 Appropriations Act, the agency shall establish and implement a

938 state Title XIX Long-Term Care Reimbursement Plan for nursing

939 home care in order to provide care and services in conformance

940 with the applicable state and federal laws, rules, regulations,

941 and quality and safety standards and to ensure that individuals

942 eligible for medical assistance have reasonable geographic

943 access to such care.

944 1. The agency shall amend the long-term care reimbursement

945 plan and cost reporting system to create direct care and

946 indirect care subcomponents of the patient care component of the

947 per diem rate. These two subcomponents together shall equal the

948 patient care component of the per diem rate. Separate prices

949 shall be calculated for each patient care subcomponent,

950 initially based on the September 2016 rate setting cost reports

951 and subsequently based on the most recently audited cost report

952 used during a rebasing year. The direct care subcomponent of the

953 per diem rate for any providers still being reimbursed on a cost

954 basis shall be limited by the cost-based class ceiling, and the

955 indirect care subcomponent may be limited by the lower of the

956 cost-based class ceiling, the target rate class ceiling, or the

957 individual provider target. The ceilings and targets apply only

958 to providers being reimbursed on a cost-based system. Effective

959 October 1, 2018, a prospective payment methodology shall be

960 implemented for rate setting purposes with the following

961 parameters:

962 a. Peer Groups, including:

963 (I) North-SMMC Regions 1-9, less Palm Beach and Okeechobee

964 Counties; and

965 (II) South-SMMC Regions 10-11, plus Palm Beach and

966 Okeechobee Counties.

967 b. Percentage of Median Costs based on the cost reports

968 used for September 2016 rate setting:

969 (I) Direct Care Costs........................100 percent.

970 (II) Indirect Care Costs......................92 percent.

971 (III) Operating Costs.........................86 percent.

972 c. Floors:

973 (I) Direct Care Component.....................95 percent.

974 (II) Indirect Care Component................92.5 percent.

975 (III) Operating Component...........................None.

976 d. Pass-through Payments..................Real Estate and

977 ...............................................Personal Property

978 ...................................Taxes and Property Insurance.

979 e. Quality Incentive Program Payment

980 Pool.....................................10 percent of September

981 .......................................2016 non-property related

982 ................................payments of included facilities.

983 f. Quality Score Threshold to

Qualify

Quality

for Quality

984 Incentive Payment...........................................20th

985 ..............................percentile of included facilities.

986 g. Fair Rental Value System Payment Parameters:

987 (I) Building Value per Square Foot based on 2018 RS Means.

988 (II) Land Valuation...10 percent of Gross Building value.

989 (III) Facility Square Footage......Actual Square Footage.

990 (IV) Movable Equipment Allowance..........$8,000 per bed.

991 (V) Obsolescence Factor......................1.5 percent.

992 (VI) Fair Rental Rate of Return................8 percent.

993 (VII) Minimum Occupancy.......................90 percent.

994 (VIII) Maximum Facility Age.....................40 years.

995 (IX) Minimum Square Footage per Bed..................350.

996 (X) Maximum Square Footage for Bed...................500.

997 (XI) Minimum Cost of a renovation/replacements$500 per bed.

998 h. Ventilator Supplemental payment of $200 per Medicaid day

999 of 40,000 ventilator Medicaid days per fiscal year.

1000 2.

The agency shall revise its methodology for

calculat

ing

1001

Q

uality

I

ncentive

Program

payments to include the results of

1002

consumer satisfaction surveys conducted pursuant to s. 400.0225

1003

as a measure of nursing home quality. The agency shall so revise

1004

the methodology after the surveys have been in effect for an

1005

amount of time the agency deems sufficient for statistical and

1006

scientific validity as a meaningful quality measure that may be

1007

incorporated into the methodology.

1008

3.

The direct care subcomponent shall include salaries and

1009 benefits of direct care staff providing nursing services

1010 including registered nurses, licensed practical nurses, and

1011 certified nursing assistants who deliver care directly to

1012 residents in the nursing home facility, allowable therapy costs,

1013 and dietary costs. This excludes nursing administration, staff

1014 development, the staffing coordinator, and the administrative

1015 portion of the minimum data set and care plan coordinators. The

1016 direct care subcomponent also includes medically necessary

1017 dental care, vision care, hearing care, and podiatric care.

1018

4.

3.

All other patient care costs shall be included in the

1019 indirect care cost subcomponent of the patient care per diem

1020 rate, including complex medical equipment, medical supplies, and

1021 other allowable ancillary costs. Costs may not be allocated

1022 directly or indirectly to the direct care subcomponent from a

1023 home office or management company.

1024

5.

4.

On July 1 of each year, the agency shall report to the

1025 Legislature direct and indirect care costs, including average

1026 direct and indirect care costs per resident per facility and

1027 direct care and indirect care salaries and benefits per category

1028 of staff member per facility.

1029

6.

5.

Every fourth year, the agency shall rebase nursing

1030 home prospective payment rates to reflect changes in cost based

1031 on the most recently audited cost report for each participating

1032 provider.

1033

7.

6.

A direct care supplemental payment may be made to

1034 providers whose direct care hours per patient day are above the

1035 80th percentile and who provide Medicaid services to a larger

1036 percentage of Medicaid patients than the state average.

1037

8.

7.

Pediatric, Florida Department of Veterans Affairs, and

1038 government-owned facilities are exempt from the pricing model

1039 established in this subsection and shall remain on a cost-based

1040 prospective payment system. Effective October 1, 2018, the

1041 agency shall set rates for all facilities remaining on a cost

1042 based prospective payment system using each facility’s most

1043 recently audited cost report, eliminating retroactive

1044 settlements.

1045

9

.

By October 1, 2025, and each year thereafter

,

the agency

1046

shall submit

to the Governor, the President of the Senate, and

1047

the Speaker of the House of Representatives a report

on

each

1048

Quality Incentive Program

p

ayment made pursuant to sub

1049

subparagraph 1.e. The report must

, at a minimum, include all of

1050

the following information

:

1051

a.

The name of each facility that received a Quality

1052

Incentive Program

p

ayment

and t

he dollar amount

of such payment

1053

each facility received.

1054

b

.

The total number of quality incentive metric points

1055

awarded by the agency to each facility

and t

he number of points

1056

awarded by the agency for each individual quality metric

1057

measured.

1058

c

.

An examination of any trends in the improvement

of

the

1059

quality of care provided to nursing home residents

which

may be

1060

attributable to incentive payments received

under

the Quality

1061

Incentive Program. Th

e agency shall

include

examination of

1062

trends both for the program as a whole as well as for each

1063

individual quality metric used by the agency to award program

1064

payments.

1065

1066 It is the intent of the Legislature that the reimbursement plan

1067 achieve the goal of providing access to health care for nursing

1068 home residents who require large amounts of care while

1069 encouraging diversion services as an alternative to nursing home

1070 care for residents who can be served within the community. The

1071 agency shall base the establishment of any maximum rate of

1072 payment, whether overall or component, on the available moneys

1073 as provided for in the General Appropriations Act. The agency

1074 may base the maximum rate of payment on the results of

1075 scientifically valid analysis and conclusions derived from

1076 objective statistical data pertinent to the particular maximum

1077 rate of payment. The agency shall base the rates of payments in

1078 accordance with the minimum wage requirements as provided in the

1079 General Appropriations Act.

1080 Section 14. Present subsection (10) of section 409.909,

1081 Florida Statutes, as amended by section 5 of chapter 2024-12,

1082 Laws of Florida, is redesignated as subsection (9), and

1083 paragraph (a) of subsection (6) and present subsection (9) of

1084 that section are amended, to read:

1085 409.909 Statewide Medicaid Residency Program.—

1086 (6) The Slots for Doctors Program is established to address

1087 the physician workforce shortage by increasing the supply of

1088 highly trained physicians through the creation of new resident

1089 positions, which will increase access to care and improve health

1090 outcomes for Medicaid recipients.

1091 (a)1. Notwithstanding subsection (4), the agency shall

1092 annually allocate $100,000 to hospitals, qualifying

1093 institutions, and behavioral health teaching hospitals

1094 designated under s. 395.902

,

for each newly created resident

1095 position that is first filled on or after June 1, 2023, and

1096 filled thereafter, and that is accredited by the Accreditation

1097 Council for Graduate Medical Education or the Osteopathic

1098 Postdoctoral Training Institution in an initial or established

1099 accredited training program which is in a physician specialty or

1100 subspecialty in a statewide supply-and-demand deficit.

1101 2. Notwithstanding the requirement that a new resident

1102 position be created to receive funding under this subsection,

1103 the agency may allocate $100,000 to hospitals and qualifying

1104 institutions, pursuant to subparagraph 1., for up to

100

200

1105 resident positions that existed before July 1, 2023, if such

1106 resident position:

1107 a. Is in a physician specialty or subspecialty experiencing

1108 a statewide supply-and-demand deficit;

1109 b. Has been unfilled for a period of 3 or more years;

1110 c. Is subsequently filled on or after June 1, 2024, and

1111 remains filled thereafter; and

1112 d. Is accredited by the Accreditation Council for Graduate

1113 Medical Education or the Osteopathic Postdoctoral Training

1114 Institution in an initial or established accredited training

1115 program.

1116 3. If applications for resident positions under this

1117 paragraph exceed the number of authorized resident positions or

1118 the available funding allocated, the agency shall prioritize

1119 applications for resident positions that are in a primary care

1120 specialty as specified in paragraph (2)(a).

1121

(9) The Graduate Medical Education Committee is created

1122

within the agency.

1123

(a) The committee shall be composed of the following

1124

members:

1125

1. Three deans, or their designees, from medical schools in

1126

this state, appointed by the chair of the Council of Florida

1127

Medical School Deans.

1128

2. Four members appointed by the Governor, one of whom is a

1129

representative of the Florida Medical Association or the Florida

1130

Osteopathic Medical Association who has supervised or is

1131

currently supervising residents, one of whom is a member of the

1132

Florida Hospital Association, one of whom is a member of the

1133

Safety Net Hospital Alliance, and one of whom is a physician

1134

licensed under chapter 458 or chapter 459 practicing at a

1135

qualifying institution.

1136

3. Two members appointed by the Secretary of Health Care

1137

Administration, one of whom represents a statutory teaching

1138

hospital as defined in s. 408.07(46) and one of whom is a

1139

physician who has supervised or is currently supervising

1140

residents.

1141

4. Two members appointed by the State Surgeon General, one

1142

of whom must represent a teaching hospital as defined in s.

1143

408.07 and one of whom is a physician who has supervised or is

1144

currently supervising residents or interns.

1145

5. Two members, one appointed by the President of the

1146

Senate and one appointed by the Speaker of the House of

1147

Representatives.

1148

(b)1. The members of the committee appointed under

1149

subparagraph (a)1. shall serve 4-year terms. When such members’

1150

terms expire, the chair of the Council of Florida Medical School

1151

Deans shall appoint new members as detailed in subparagraph

1152

(a)1. from different medical schools on a rotating basis and may

1153

not reappoint a dean from a medical school that has been

1154

represented on the committee until all medical schools in the

1155

state have had an opportunity to be represented on the

1156

committee.

1157

2. The members of the committee appointed under

1158

subparagraphs (a)2.-4. shall serve 4-year terms, with the

1159

initial term being 3 years for members appointed under

1160

subparagraph (a)4. and 2 years for members appointed under

1161

subparagraph (a)3. The committee shall elect a chair to serve

1162

for a 1-year term.

1163

(c) Members shall serve without compensation but are

1164

entitled to reimbursement for per diem and travel expenses

1165

pursuant to s. 112.061.

1166

(d) The committee shall convene its first meeting by July

1167

1, 2024, and shall meet as often as necessary to conduct its

1168

business, but at least twice annually, at the call of the chair.

1169

The committee may conduct its meetings through teleconference or

1170

other electronic means. A majority of the members of the

1171

committee constitutes a quorum, and a meeting may not be held

1172

with less than a quorum present. The affirmative vote of a

1173

majority of the members of the committee present is necessary

1174

for any official action by the committee.

1175

(e) Beginning on July 1, 2025, the committee shall submit

1176

an annual report to the Governor, the President of the Senate,

1177

and the Speaker of the House of Representatives which must, at a

1178

minimum, detail all of the following:

1179

1. The role of residents and medical faculty in the

1180

provision of health care.

1181

2. The relationship of graduate medical education to the

1182

state’s physician workforce.

1183

3. The typical workload for residents and the role such

1184

workload plays in retaining physicians in the long-term

1185

workforce.

1186

4. The costs of training medical residents for hospitals

1187

and qualifying institutions.

1188

5. The availability and adequacy of all sources of revenue

1189

available to support graduate medical education.

1190

6. The use of state funds, including, but not limited to,

1191

intergovernmental transfers, for graduate medical education for

1192

each hospital or qualifying institution receiving such funds.

1193

(f) The agency shall provide reasonable and necessary

1194

support staff and materials to assist the committee in the

1195

performance of its duties. The agency shall also provide the

1196

information obtained pursuant to subsection (8) to the committee

1197

and assist the committee, as requested, in obtaining any other

1198

information deemed necessary by the committee to produce its

1199

report.

1200 Section 15. Subsection (1), paragraph (d) of subsection

1201 (2), and paragraph (a) of subsection (5) of section 409.91256,

1202 Florida Statutes, are amended to read:

1203 409.91256 Training, Education, and Clinicals in Health

1204 (TEACH) Funding Program.—

1205 (1) PURPOSE AND INTENT.—The Training, Education, and

1206 Clinicals in Health (TEACH) Funding Program is created to

1207 provide a high-quality educational experience while supporting

1208 participating federally qualified health centers, community

1209 mental health centers, rural health clinics,

and

certified

1210 community behavioral health clinics

, and publicly funded

1211

nonprofit organizations serving Medicaid recipients or other

1212

low-income patients in areas designated as health professional

1213

shortage areas and approved by the agency

by offsetting

1214 administrative costs and loss of revenue associated with

1215 training residents and students to become licensed health care

1216 practitioners. Further, it is the intent of the Legislature to

1217 use the program to support the state Medicaid program and

1218 underserved populations by expanding the available health care

1219 workforce.

1220 (2) DEFINITIONS.—As used in this section, the term:

1221 (d) “Qualified facility” means a federally qualified health

1222 center, a community mental health center,

a

rural health clinic,

1223

or

a certified community behavioral health clinic

, or a publicly

1224

funded nonprofit organization serving Medicaid recipients or

1225

other low-income patients in

an

area designated as

a

health

1226

professional shortage area and approved by the agency

.

1227 (5) REIMBURSEMENT.—Qualified facilities may be reimbursed

1228 under this section only to offset the administrative costs or

1229 lost revenue associated with training students, allopathic

1230 residents, osteopathic residents, or dental residents who are

1231 enrolled in an accredited educational or residency program based

1232 in this state.

1233 (a) Subject to an appropriation, the agency may reimburse a

1234 qualified facility based on the number of clinical training

1235 hours reported under subparagraph (3)(e)1. The allowed

1236 reimbursement per student is as follows:

1237 1. A medical or dental resident at a rate of $50 per hour.

1238 2. A first-year medical student at a rate of $27 per hour.

1239 3. A second-year medical student at a rate of $27 per hour.

1240 4. A third-year medical student at a rate of $29 per hour.

1241 5. A fourth-year medical student at a rate of $29 per hour.

1242 6. A dental student at a rate of $22 per hour.

1243 7. An advanced practice registered nursing student at a

1244 rate of $22 per hour.

1245 8. A physician assistant student at a rate of $22 per hour.

1246 9.

A nursing student at a rate of $22 per hour.

1247

10.

A behavioral health student at a rate of $15 per hour.

1248

11.

10.

A dental hygiene student at a rate of $15 per hour.

1249 Section 16. Paragraph (e) of subsection (3) of section

1250 409.967, Florida Statutes, is amended to read:

1251 409.967 Managed care plan accountability.—

1252 (3) ACHIEVED SAVINGS REBATE.—

1253 (e) Once the certified public accountant completes the

1254 audit, the certified public accountant shall submit an audit

1255 report to the agency attesting to the achieved savings of the

1256 plan.

The agency shall review the report to determine compliance

1257

with the requirements of this subsection. The agency shall

1258

notify the certified public accountant of any deficiencies in

1259

the audit report. The certified public accountant must correct

1260

such deficiencies in the audit report and resubmit the revised

1261

audit report to the agency before the report is considered

1262

final. Once finalized,

the results of the audit report are

1263 dispositive.

1264 Section 17. Section 409.9745, Florida Statutes, is amended

1265 to read:

1266 409.9745 Managed care plan biomarker testing.—

1267 (1) A managed care plan must provide coverage for biomarker

1268 testing for recipients, as authorized under s. 409.906, at the

1269 same scope, duration, and frequency as the Medicaid program

1270 provides for other medically necessary treatments.

1271

(a)

(2)

A recipient and health care provider shall have

1272 access to a clear and convenient process to request

1273 authorization for biomarker testing as provided under this

1274 section. Such process shall be made readily accessible on the

1275 website of the managed care plan.

1276

(b)

(3)

This section does not require coverage of biomarker

1277 testing for screening purposes.

1278

(c)

(4)

The agency shall include the rate impact of this

1279 section in the applicable Medicaid managed medical assistance

1280 program and long-term care managed care program rates.

1281

(2) A managed care plan must provide coverage for blood

1282

based biomarker tests for colorectal cancer screening covered

1283

under a National Coverage Determination from the Centers for

1284

Medicare and Medicaid Services at the same scope and frequency

1285

as described in the National Coverage Determination.

1286 Section 18. Subsection (4) of section 409.977, Florida

1287 Statutes, is amended to read:

1288 409.977 Enrollment.—

1289 (4) The agency shall develop a process to enable a

1290 recipient with access to employer-sponsored health care coverage

1291 to opt out of all managed care plans and to use Medicaid

1292 financial assistance to pay for the recipient’s share of the

1293 cost in such employer-sponsored coverage. The agency shall also

1294 enable recipients with access to other insurance or related

1295 products providing access to health care services created

1296 pursuant to state law, including any product available under the

1297 Florida Health Choices Program, or any health exchange, to opt

1298 out. The amount of financial assistance provided for each

1299 recipient may not exceed the amount of the Medicaid premium that

1300 would have been paid to a managed care plan for that recipient.

1301 The agency shall require Medicaid recipients with access to

1302 employer-sponsored health care coverage to enroll in that

1303 coverage and use Medicaid financial assistance to pay for the

1304 recipient’s share of the cost for such coverage. The amount of

1305 financial assistance provided for each recipient may not exceed

1306 the amount of the Medicaid premium that would have been paid to

1307 a managed care plan for that recipient.

The agency may exceed

1308

this amount for a high-cost patient if it determines it would be

1309

cost effective to do so. The agency shall annually, beginning

1310

June 30, 2026, submit an annual report on the program to the

1311

L

egislature including, but not limited to, the level of

1312

participation; participant demographics, income levels, type of

1313

employer-based coverage, and amount of health care utilization;

1314

and a cost-effectiveness analysis both in the aggregate and on

1315

an individual patient basis.

1316 Section 19. Paragraph (b) of subsection (3) of section

1317 430.84, Florida Statutes, is amended to read:

1318 430.84 Program of All-Inclusive Care for the Elderly.—

1319 (3) PACE ORGANIZATION SELECTION.—The agency, in

1320 consultation with the department, shall, on a continuous basis,

1321 review and consider applications required by the CMS for PACE

1322 that have been submitted to the agency by entities seeking

1323 initial state approval to become PACE organizations. Notice of

1324 such applications shall be published in the Florida

1325 Administrative Register.

1326 (b) Each applicant must propose to serve a unique and

1327 defined geographic service area

.

In designating a service area

1328

under a contract with a PACE organization, the state

1329

administering agency may exclude from designation an area that

1330

is already covered under another PACE organization contract in

1331

order to avoid unnecessary duplication of services and avoid

1332

impairing the financial service viability of an existing PACE

1333

organization. However, if a new applicant submits a letter of

1334

intent to provide PACE services in an area where an existing

1335

PACE organization is under contract and has been operating for

1336

at least 10 years, the state shall determine whether there is an

1337

unmet need that could be provided by the new PACE organization

1338

and the applicant must satisfactorily demonstrate to the state

1339

administering agency that there is justification for the

1340

proposed PACE organization in such service area. All applicants

1341

must demonstrate in the application that the PACE services

1342

provided by the proposed PACE organization will be comprehensive

1343

and organized to meet all state and CMS requirements

without

1344

duplication of services or target populations

.

No more than one

1345

PACE organization may be authorized to provide services within

1346

any unique and defined geographic service area

.

1347 Section 20.

(

1)

To support and enhance quality outcomes in

1348

Florida’s nursing homes,

t

he Agency for Health Care

1349

Administration shall contract with a third-party vendor

to

1350

conduct a comprehensive study of nursing home quality incentive

1351

programs in other states

.

1352

(a)

At a minimum,

the study must include

a detailed

1353

analysis of quality incentive programs implemented in each

of

1354

the

state

s

examined

,

i

dentify components of

such

programs

which

1355

have demonstrably improved nursing home quality outcomes

, and

1356

p

rovide recommendations to modify or enhance

this state’s

1357

existing Medicaid Quality Incentive Program based on its

1358

historical performance and trends since

it was first

1359

implement

ed

.

1360

(b)

The study must a

lso include

:

1361

1.

A

n in-depth review of emerging and existing technologies

1362

applicable to nursing home care

and

an

analysis of how their

1363

adoption in

this state

could improve quality of care

,

1364

operational efficiency

, and

quality of life outcomes for nursing

1365

home residents

; and

1366

2.

An

examination of other states’ Medicaid add-on payment

1367

structures related to the provision of ventilator care,

1368

bariatric services, and behavioral health services.

1369

(2)

The agency shall submit a

final report

on the study

,

1370

including findings and actionable recommendations, to the

1371

Governor, the

President of the Senate

,

and the Speaker of the

1372

House of Representatives

by

January 5

, 202

6

.

1373 Section 21. This act shall take effect July 1, 2025.

Back to the full text